19 June, 2023
Tiny packets of molecular cargo shed by cancer cells seed the foundations for metastasis at distant sites in the body.
01 June, 2023
The partnership seeks to leverage expertise in vaccine development, digital health systems, and biobanking to advance global health equity and foster innovative solutions in Saudi Arabia and beyond.
09 May, 2023
Biopharming technique yields cost-effective and environmentally friendly antimicrobial peptides.
30 April, 2023
Prof. Sahika Inal and her team are collaborating closely with Ashraf Dada, Fatima Alhamlan and co-workers at King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Saudi Arabia. The aim of the partnership is to help develop and trial bioelectronic sensors that will aid in cheap, accurate and rapid pathogen detection.
17 April, 2023
An electronic sensor based on individual atoms anchored to MXene nanomaterials can detect tumor-specific biomarkers.
16 April, 2023
In a research partnership between KAUST, King Abdulaziz University, Jeddah (KAU) and King Abdulaziz University Hospital, Jeddah (KAUH), scientists have conducted a first-of-its-kind study in the Kingdom that compares stem cells derived from a unique cohort of Saudi Klinefelter patients with a group of North American and European descent.
In the media
24 August, 2022
Enhancement of adhesion molecules improves the ability of blood-forming stem cells to take root in transplant recipients.
16 August, 2022
KAUST scientists are researching RNA-based approaches to treat progeria, an early aging disease that affects children and adolescents.
16 August, 2022
KAUST bioscientists are developing new methods to combine single-cell sequencing datasets, which will help to improve understanding of cellular identity and function. The team has used the method to study the bone marrow microenvironment in greater detail.
28 July, 2022
KAUST Smart-Health Initiative has been honored to host Junfeng (Jim) Zhang at KAUST during his sabbatical. Prof. Zhang has been developing several air pollution studies in collaboration with KAUST faculty and staff.
03 July, 2022
Abnormal protein tied to Wiskott-Aldrich syndrome found to control gene splicing.
29 June, 2022
A newly identified heat-stable Cas13 enzyme could lead to improved diagnostics and new biotechnological applications.
28 June, 2022
Nanotechnology that accelerates the transition of stem cells into bone could advance regenerative medicine.
24 May, 2022
A new AI diagnostic tool developed by KAUST scientists allows doctors to visualize lung damage caused by COVID-19 in more detail.
23 November, 2021
Top medical students from AlFaisal University will undertake their Ph.D. degree at KAUST to obtain the necessary training needed to conduct basic research and the implementation of smart-health tools and methods in the Saudi healthcare delivery system.
15 November, 2021
The goal of this program is to offer Saudi and resident students of medicine at Al-Faisal University state-of-the-art educational and research facilities. The program is tailored to those who aspire to build their careers as physician-scientists and will be the leaders of tomorrow.
19 September, 2021
President Chan receives the Kingdom’s first, KAUST-developed COVID-19 RT-PCR test, processed by KAUST startup Noor DX.
25 August, 2021
The man behind the kingdom’s vaccine-development center is building an entire industry from scratch.
08 June, 2021
Global experts and participants in the field of brain research gathered online for a two-day conference, Integrative modeling of brain energy metabolism, presented by the Blue Brain Project Alliance.
02 June, 2021
A new sensor, based on organic transistors, combines speed and accuracy in detecting single-molecule antigens belonging to the viruses that cause COVID-19 and MERS.
15 April, 2021
KAUST Distinguished Professor Pierre Magistretti, Director of the newly launched Smart-Health Initiative, took part in a virtual event put on by the U.S. Chamber of Commerce and the Kingdom of Saudi Arabia Ministry of Investment.
05 April, 2021
KAUST has recently launched a multidisciplinary scientific and clinical research and innovation health initiative dubbed the KAUST Smart-Health Initiative (SHI).
02 February, 2021
The Smart Health Initiative aims to enhance Saudi Arabia's capabilities in what Magistretti describes as precision medicine.
20 December, 2020
KAUST announced a collaboration with Janssen Pharmaceutical Companies of Johnson & Johnson to explore opportunities for research and innovation in the area of neglected tropical diseases, with a focus on dengue fever.
08 November, 2020
The COVID-19 pandemic has activated vital innovation and R&D initiatives to tackle the crippling effects, health ramifications, and overall impact of the coronavirus on global societies and economies.